Currently, an estimated 285 million people worldwide suffer from hereditary, rare, age-related and degenerative eye diseases. The development of new treatments for eye diseases has brought more interest and opportunities. At CD BioSciences, we have extensive and comprehensive clinical research and development experience in numerous ophthalmic indications. Whether you are developing eye treatment equipment, drug delivery, or looking for a clinical development solution, our industry-leading expertise and experience will provide you from all stages of trial design to commercialization and beyond to maximize success of your ophthalmic clinical research.
Ophthalmology Experience
Ophthalmology clinical research is highly specialized and requires professional experience and expertise. CD BioSciences has a team of technical experts and scientists who have extensive experience in many indications and are good at developing clinical testing programs. In order to minimize the timeline of your ophthalmic drugs, CD BioSciences' comprehensive clinical development services run from Phases 1 to 4 in all areas of ophthalmology.
CD BioSciences has ophthalmology experience in a variety of indications, including but not limited to:
|
Ophthalmology Areas of Expertise |
|
|
|
Experience in Multiple Treatment Modalities
As a leading global provider of clinical services, we are committed to helping our customers bring leading eye disease medicines and state-of-the-art equipment to market. Whether you are developing contact lenses, intraocular lenses, solutions or drug delivery equipment, our industry-leading expertise and experience will show you the ultimate market approach. Our technical experts use proven methods and follow international requirements to develop standard clinical testing procedures for these devices and other ophthalmic products.
|
Therapy Modalities of Expertise |
|
Why Choose CD BioSciences?
CD BioSciences' scientists are dedicated to bringing together years of valuable experience to help our clients shorten the clinical trial journey. For further details, please don't hesitate to contact us.